Impact of brining and drying processes on the nutritive value of tambaqui fish (Colossoma macropomum).

Preservation of fish as diet ingredient is challenging in many tropical regions due to poor socioeconomic conditions and lack of freezing facilities. So, alternative preservation techniques could be viable to address the issue. The present study evaluated the effect of brine salting (15% w/v) prior to drying at different temperatures on the nutrient profiles of tambaqui fish (Colossoma macropomum). Whole fish samples (n = 48; 792 ± 16 g; 8 months old) were grouped into two as brine-salted and non-salted, and treated at seven different drying temperatures of 30, 35, 40, 45, 50, 55 and 60°C for a period of 23 h each. To evaluate the impact of Maillard reaction, reactive lysine was also quantified. Drying temperature had no effect on the evaluated macro- and micro-nutrients of tambaqui fish (P > 0.05) while brining reduced the overall protein concentration by 6% (58.8 to 55.4 g/100 g DM; P = 0.004). Brining significantly reduced many amino acids: taurine by 56% (7.1 to 3.1 g/kg; P < 0.001), methionine 17% (14.7 to 12.1 g/kg; P < 0.001), cysteine 11% (5.1 to 4.4 g/kg, P = 0.016), and reactive lysine 11% (52.0 to 46.4 g/kg; P = 0.004). However, alanine, arginine, and serine were not affected by brining (P > 0.05). Brining also reduced the concentrations of Se by 14% (149 to 128 µg/kg DM; P = 0.020), iodine 38% (604 to 373 µg/kg DM; P = 0.020), K 42% (9.71 to 5.61 g/kg DM; P < 0.001) and Mg 18% (1.32 to 1.10 g/kg DM; P = < 0.001) versus an anticipated vast increase in Na by 744% (2.70 to 22.90 g/kg DM; P < 0.001) and ash 28% (12.4 to 16.0 g/100g DM; P < 0.001) concentration. Neither brining nor drying temperature induced changes in % lysine reactivity and fat content of tambaqui fish (P > 0.05). Agreeably, results of multivariate analysis showed a negative association between brining, Na, and ash on one side of the component and most other nutrients on the other component. In conclusion, drying without brining may better preserve the nutritive value of tambaqui fish. However, as a practical remark to the industry sector, it is recommended that the final product may further evaluated for any pathogen of economic or public health importance.

An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients.

Nucleic acid polymers (NAPs) are an attractive treatment modality for chronic hepatitis B (CHB), with REP2139 and REP2165 having shown efficacy in CHB patients. A subset of patients achieve functional cure, whereas the others exhibit a moderate response or are non-responders. NAP efficacy has been difficult to recapitulate in animal models, with the duck hepatitis B virus (DHBV) model showing some promise but remaining underexplored for NAP efficacy testing. Here we report on an optimized in vivo DHBV duck model and explore several characteristics of NAP treatment. REP2139 was efficacious in reducing DHBV DNA and DHBsAg levels in approximately half of the treated ducks, whether administered intraperitoneally or subcutaneously. Intrahepatic or serum NAP concentrations did not correlate with efficacy, nor did the appearance of anti-DHBsAg antibodies. Furthermore, NAP efficacy was only observed in experimentally infected ducks, not in endogenously infected ducks (vertical transmission). REP2139 add-on to entecavir treatment induced a deeper and more sustained virological response compared to entecavir monotherapy. Destabilized REP2165 showed a different activity profile with a more homogenous antiviral response followed by a faster rebound. In conclusion, subcutaneous administration of NAPs in the DHBV duck model provides a useful tool for in vivo evaluation of NAPs. It recapitulates many aspects of this class of compound's efficacy in CHB patients, most notably the clear division between responders and non-responders.